Loading…
Cannabidiol Research Expansion Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,548 other S bills in the 114th — cohort avg 43d
Cannabidiol Research Expansion Act This bill requires the Drug Enforcement Administration (DEA) and the Department of Health and Human Services to each evaluate whether cannabidiol, the nonpsychoactive substance derived from marijuana or the synthetic formulation, should be a controlled substance under the Controlled Substances Act. After taking into consideration the evaluations, the DEA must initiate proceedings for classifying cannabidiol as a controlled substance if control is warranted. The bill expands the authority for: (1) conducting medical research on cannabidiol, and (2) possessing or transporting cannabidiol or any other nonpsychoactive component of marijuana for certain medicinal purposes. Physicians who are licensed under state law may discuss the potential harms and benefits of cannabidiol or those components of marijuana as a treatment with their patients or the legal guardians of underage patients. The bill terminates four years after enactment.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2016 · fourth_quarter · Science/Technology
S. 524/H.R. 953 Comprehensive Addiction and Recovery Act S. 2011/S. 2014 Innovations for Healthier Americans Act S. 3077 Marijuana Effective Drug Studies (MEDS) Act S. 3269 Cannabidiol Research Act H.R. 6 21st Century Cures Act and Senate version H.R. 5549 Medical Marijuana Research Act H.Res. 725 To consider S. 524 to authorize the Attorney General to award grants to address prescription opioid abuse and heroin use. H.Res. 809 To consider the conference report to S. 524 to authorize the Attorney General to award grants to address prescription opioid abuse and heroin use FY2017 Department of Defense Appropriations Bills - funding for psychological research FY2017 Commerce/Justice/Science Appropriations Bills - funding for psychological research FY2017 Department of Veterans Affairs Appropriations Bills - funding for psychological research
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S5169)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2016 · fourth_quarter · Science/Technology
S. 524/H.R. 953 Comprehensive Addiction and Recovery Act S. 2011/S. 2014 Innovations for Healthier Americans Act S. 3077 Marijuana Effective Drug Studies (MEDS) Act S. 3269 Cannabidiol Research Act H.R. 6 21st Century Cures Act and Senate version H.R. 5549 Medical Marijuana Research Act H.Res. 725 To consider S. 524 to authorize the Attorney General to award grants to address prescription opioid abuse and heroin use. H.Res. 809 To consider the conference report to S. 524 to authorize the Attorney General to award grants to address prescription opioid abuse and heroin use FY2017 Department of Defense Appropriations Bills - funding for psychological research FY2017 Commerce/Justice/Science Appropriations Bills - funding for psychological research FY2017 Department of Veterans Affairs Appropriations Bills - funding for psychological research
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2016 · third_quarter · Science/Technology
S. 524/H.R. 953 Comprehensive Addiction and Recovery Act S. 2011/S. 2014 Innovations for Healthier Americans Act S. 3077 Marijuana Effective Drug Studies (MEDS) Act S. 3269 Cannabidiol Research Act H.R. 6 21st Century Cures Act and Senate version H.R. 5549 Medical Marijuana Research Act H.Res. 725 To consider S. 524 to authorize the Attorney General to award grants to address prescription opioid abuse and heroin use. H.Res. 809 To consider the conference report to S. 524 to authorize the Attorney General to award grants to address prescription opioid abuse and heroin use FY2017 Department of Defense Appropriations Bills - funding for psychological research FY2017 Commerce/Justice/Science Appropriations Bills - funding for psychological research FY2017 Department of Veterans Affairs Appropriations Bills - funding for psychological research
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
| Republican |
| NC |